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ABSTRACT
We previously reported that specific oxysterols stimulate osteogenic differentiation of pluripotent bone marrow stromal cells (MSCs)
through activation of hedgehog (Hh) signaling and may serve as potential future therapies for intervention in osteopenia and
osteoporosis. In this study we report that the osteogenic oxysterol 20(S)-hydroxycholesterol (20S) induces the expression of genes
associated with Notch signaling. Using M2-10B4 (M2) MSCs, we found that 20S significantly induced HES-1, HEY-1, and HEY-2 mRNA
expression compared with untreated cells, with maximal induction after 48 hours, whereas the nonosteogenic oxysterols did not. Similar
observations were made when M2 cells were treated with sonic hedgehog (Shh), and the specific Hh pathway inhibitor cyclopamine
blocked 20S-induced Notch target gene expression. 20S did not induce Notch target genes in Smo
 /  mouse embryonic fibroblasts,
further confirmingthe roleofHh signalingin20S-inducedexpressionofNotchtarget genes.Despitetheinability ofliver X-receptor(LXR)
synthetic ligand TO901317 to induce Notch target genes in M2 cells, LXR knockdown studies using siRNA showed inhibition of 20S-
induced HEY-1 but not HES-1 expression, suggesting the partial role of LXR signaling in MSC responses to 20S. Moreover, 20S-induced
Notch target gene expression was independent of canonical Notch signaling because neither 20S nor Shh induced CBF1 luciferase
reporter activity or NICD protein accumulation in the nucleus, which are hallmarks of canonical Notch signaling activation. Finally, HES-1
andHEY-1siRNA transfection significantlyinhibited20S-inducedosteogenic genes,suggestingthat thepro-osteogenic effects of20Sare
regulated in part by HES-1 and HEY-1.  2010 American Society for Bone and Mineral Research.
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Introduction
T
he Notch signaling pathway is an evolutionarily conserved
intercellular signalingmechanism thatplays aprominentrole
in cell proliferation, differentiation, and survival.
(1,2) The
canonical Notch signaling pathway is activated when Notch
receptors (Notch-1, -2, -3, and -4) interact with ligands [Jagged-1
and -2 and Delta-like (Dll-1, -3, and -4)] on adjacent cells,
triggering proteolytic cleavage of the receptor by the presenilin–
g-secretase complex.
(1,2) This releases the Notch intracellular
domain (NICD), which translocates to the nucleus and binds the
CBF-1 DNA-binding protein, thereby inducing the expression of
Notch target genes, including the isoforms of HES (HES-1, -3,
and -5) and HEY (HEY-1, -2, and -3).
(3) These Notch target genes
are involved in various biologic processes, including angiogen-
esis, osteogenesis, adipogenesis, myogenesis, somatogenesis,
and neurogenesis.
(4–9) Regulation of Notch signaling pathway
and target gene expression is important in embryonic and
postembryonic development and tissue homeostasis.
(1,10–12)
However, it remains controversial as to whether Notch signaling
acts as a positive or negative regulator of osteogenic
differentiationinosteoblastprogenitorcellsandboneformation.
For example, Dll-3- or presenilin-1-deficient mice exhibit severe
skeletal defects,
(8,13,14) and overexpression of Notch-1, HES-1, or
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782HEY-1 enhances osteogenic differentiation of MSCs
(15–17) in part
through positive regulation of and cooperation with Runx2,
suggesting that Notch signaling may play positive roles in bone
formation. On the other hand, presenilin-2 null mice have greatly
increased trabecular bone mass, and HES or HEY proteins were
shown to inhibit Runx2 transcriptional activity in CHO and ST2
cells, suggesting the negative role of Notch signaling in
osteogenesis.
(18) However, it also has been suggested that
HES and/or HEY expression induced by Notch signaling may be
important in regulating bone density during aging by main-
taining a sufficient pool of bone marrow progenitor cells for
osteogenesis.
(18) Therefore, further examination of the role of
Notch signaling in regulating osteogenesis and bone formation
is required, and it is likely that the differences in the reports cited
earlier may be due to differences in the specific experimental
models used in studying the role of Notch signaling in
osteogenesis.
In addition to canonical Notch signaling, the expression of
Notch target genes is regulated by growth factors, including
transforming drowth factor b (TGF-b), bone morphogenetic
protein (BMP), vascular endothelial growth factor (VEGF), and
sonic hedgehog (Shh).
(17,19–21) TGF-b induces HEY-1 and Jagged-
1 in epithelial cells from mammary gland, kidney tubules, and
epidermis,
(19)andBMP-9inducesHEY-1expressioninC3H10T1/2
cells.
(17) Also, Shh and VEGF induce Notch-5 and HES-1 mRNA
expression in various cells, including C3H10T1/2 cells, MNS70
neural cells, and granule neuron precursors.
(20–22) Moreover, it
has been suggested that regulation of HES-1 expression by c-Jun
kinase signaling and Hedgehog signaling may be mediated
through the activation of noncanonical Notch signaling path-
ways.
(22–24) Hence the molecular mechanisms by which growth
and differentiation factors activate the Notch signaling pathway
and induce the expression of Notch target genes require further
elucidation.
Oxysterols,alargefamilyof27-carbonoxygenatedproductsof
cholesterol present in the circulation and in human and animal
tissues,
(25) are involved in various biologic and pathologic
processes, including cholesterol efflux, lipoprotein metabolism,
cell differentiation, atherosclerosis, and apoptosis.
(26–29) We have
demonstrated previously that specific oxysterols stimulate the
osteogenic differentiation of pluripotent MSCs and inhibit their
adipogenic differentiation through the activation of Hedgehog
signaling in vitro
(30–33) and enhance bone healing in rat critical-
sized calvarial defects in vivo.
(34) Here, we report that osteogenic
oxysterols are novel activators of expression of the Notch target
genes HES-1, HEY-1, and HEY-2 in MSCs. Moreover, the induction
of Notch target gene expression by 20S is not mediated by the
canonical Notch signaling pathway but mainly by Hedgehog
signaling and in part by LXR signaling, and HES-1 and HEY-1
induction appears necessary for maximal induction of osteogen-
esis by 20S.
Materials and Methods
Cell culture and reagents
M2-10B4 (M2) pluripotent mouse marrow stromal cells and
Smo
 /  mouse embryonic fibroblasts (MEFs) were maintained as
described previously.
(31,32,35,36) Cell treatment was performed in
differentiation medium containing 5% fetal bovine serum
(FBS), 50mg/mL ascorbate, and 3mM b-glycerophosphate.
Oxysterols were purchased from Sigma-Aldrich, Co. (St. Louis,
MO, USA); N-[N-(3,5-difluorophenacetyl-L-alanyl)] S-phenylglycine
t-butyl ester (DAPT) and cyclopamine were from Calbiochem (La
Jolla, CA, USA), and recombinant mouse Shh N-terminal peptide
and Jagged-1 were from R&D Systems (Minneapolis, MN, USA).
Quantitative reverse-transcriptase polymerase chain
reaction (qRT-PCR)
Total RNA was extracted with an RNA isolation kit from
Stratagene (La Jolla, CA, USA) according to the manufacturer’s
instructions. RNA was DNase treated using a DNA-free kit from
Ambion (Austin, TX, USA). Then 3mg of RNA was reverse-
transcribed using reverse transcriptase from Stratagene (La Jolla,
CA, USA) to make single-stranded cDNA. The cDNAs then were
mixed with Qi SYBR Green Supermix (Bio-Rad, Hercules, CA, USA)
for qRT-PCR assay using a Bio-Rad I-cycler IQ quantitative
thermocycler. AllPCRsampleswerepreparedintriplicatewellsin
a96wellplate.After40cyclesofPCR,meltcurveswereexamined
to ensure primer specificity. Fold changes in gene expression
were calculated using the DDCt method and normalized to the
expression of the housekeeping gene GAPDH. Primers used
were as follows: HES-1:5 0-TACCCCAGCCAGTGTCAACA-30 and
50-CCATGATAGGCTTTGATGACTTTCT-30(37); HEY-1:5 0-TGAGCTGA-
GAAGGCTGGTAC-30 and 50-ACCCCAAACTCCGATAGTCC-50(38);
HEY-2:5 V 0-TGAGAAGACTAGTGCCAACAGC-30 and 50-TGGGCAT-
CAAAGTAGCCTTTA-30(38); Jagged-1:5 0-TGGTTGGCTGGGAAATT-
GA-30 and 50-TGGACACCAGGGCACATTC-30(39); Delta-1:5 0-CAC-
TATGGACAGTTGCTTTGAAGAGT-30 and 50-TGGCTCATAGTAATC-
CAAGATAGACG-50(40); Notch-1:5 0-GGATCACATGGACCGATTGC-30
and 50-ATCCAAAAGCCGCACGATAT-30(39); Notch-2:5 0-CCCCT-
TGCCCTCTATGTACCA-30 and 50-GGTAGGTGGGAAAGCCACACT-
30(39); ALP:5 0-AAACCCAGAACACAAGCATTCC-30 and 50-TCCAC-
CAGCAAGAAGAAGCC-30; ABCA1:5 0-TGCCACTTTCCGAATAAAGC-
30 and 50-GGAGTTGGATAACGGAAGCA-30; BSP 50-ACGCCA-
CACTTTCCACACTCTC-30 and 50-TTCCTCTTCCTCTTCTTCTTCTTC-
TTCC-30; and GAPDH:5 0- ATGGACTGTGGTCATGAGCC-30 and
50- ATTGTCAGCAATGCATCCTG-30.
CBF-1 luciferase assay
M2 cells at 70% confluency in 24 well plates were transiently
transfected with CBF-1 luciferase reporter construct pTK-
luciferase plasmid and pTK-Renilla-luciferase plasmid (Promega,
Madison, WI, USA) using Fugene 6 Transfection Reagents from
Roche (Indianapolis, IN, USA).
(2) Twenty-four hours after
transfection, the cells were treated with control vehicle or Notch
interacellular domain (NICD) overexpression vector with or without
5mM2 0 S and 200ng/mL mouse recombinant Shh for 24 and 48
hours, and Notch activation of CBF-1 was normalized to Renilla
luciferase activity. Transfection efficiency was monitored by
cotransfecting with a plasmid expressing green fluorescent protein.
Jagged-1, Notch intracellular domain (NICD), and HES-1
Western blot
For Jagged-1 Western blot, M2 cells at confluence were treated
with control vehicle (control), 5mM 20(S)-hydroxycholesterol
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of treatment, whole-cell lysates were collected, and protein
concentrations were determined using the Bio-Rad protein
assay. For NICD Western blot, M2 cells at 100% confluence were
treated with control vehicle (control) or 5mM2 0 S or cultured on
5mg/mL immobilized Jagged-1. After 48 and 72 hours, nuclear
extracts were collected and protein concentrations determined
using the Bio-Rad protein assay. For Western blotting of HES-1
and b-actin, whole-cell lysates were collected after 72 hours of
control vehicle or 5mM2 0 S treatment in M2 cells transfected
with either scramble control or HES-1 siRNA. The samples
were subjected to sodium dodecylsulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred overnight onto a
nitrocellulose membrane (Amersham Biosciences, Piscataway,
NJ, USA). Blots then were incubated with polyclonal antibodies
against HES-1 from Santa Cruz Biotechnology (Santa Cruz, CA,
Fig. 1. 20(S)-Hydroxycholesterol(20S)inducesNotchsignalingtargetgenesHES-1, HEY-1, andHEY-2inM2-10B4bonemarrowstromalcells.(A–C)M2cells
were treated at confluence with control vehicle or 5mM2 0 S,7 a-hydroxycholesterol (7-aHC), or 7-ketocholesterol (7-ketoC) for 48 hours. HES-1, HEY-1, and
HEY-2mRNAexpressionwasmeasuredbyquantitativereal-timePCR.(D–F)M2cellsweretreatedat confluencewithcontrolvehicleor5mM2 0 Sfor24,48,
and96hours.HES-1,HEY-1, andHEY-2mRNAexpressionwasmeasuredby quantitativereal-timePCR.Foldchangesingeneexpressioncomparedwiththe
control were calculated using the DDCt method and reported as the mean of triplicate determination   SD (A–C:
   p<.0001 for control, 7a-HC or 7-keto
Cversus20S; D:
   p<.0001forcontrolversus20Sat48hours;
  p<.001forcontrolversus20Sat24and96hours.E:
  p<.001forcontrolversus20Sat24
hours;
   p<.0001 for control versus 20S at 48 hours;
 p<.05 for control versus 20S at 96 hours. F:
  p<.001 for control versus 20S at 48 hours).
784 Journal of Bone and Mineral Research KIM ET AL.Fig. 2. Mechanism of HES-1 and HEY-1 induction by 20(S)-hydroxycholesterol (20S). M2 cells were treated at confluence with control vehicle, 5mM2 0 S,
200ng/mL recombinant mouse sonic hedgehog (Shh), or 2mM of LXR ligand TO901317 (TO) for 48 hours. HES-1, HEY-1, HEY-2, and ABCA1 mRNA
expression was measured by quantitative real-time PCR (A–D). For LXR siRNA experiments (E, F), M2 cells at 70% confluence were transfected with both
LXRaandLXRbsiRNAtoafinalconcentrationof25nMofeachsiRNA.ThescramblecontrolorLXRsiRNA–transfectedcellsweretreatedwithcontrolvehicle
or5mM20Sfor48hours.HES-1andHEY-1mRNAexpressionwasmeasuredbyquantitativereal-timePCR.Foldchangesingeneexpressioncomparedwith
thecontrolwerecalculatedusingtheDDCtmethodandreportedas themeanoftriplicatedetermination  SD.(A–C)
   p<.0001forcontrolversus20Sor
Shh. (D)
   p<.0001 for control versus 20S or TO. (E)
   p<.0001 for control versus 20S with or without LXR siRNA. ( F)
   p<.0001 for control versus 20S
with and without LXR siRNA and for 20S in the presence of scrambled versus LXR siRNA.
OXYSTEROL INDUCES NOTCH TARGET GENE EXPRESSION Journal of Bone and Mineral Research 785USA), and Jagged-1, NICD, and b-actin from Cell Signaling
Technology (Danvers, MA, USA). As a positive control for the
canonical Notch pathway activation, cells were cultured on
immobilized Jagged-1 from R&D Systems toinduce nuclearNICD
accumulation.
(40,41)
Alkaline phosphatase activity assay
M2 cells at confluence were treated with control vehicle (control)
or 5mM2 0 S. For experiments with immobilized Jagged-1,
M2 cells were cultured in tissue culture wells coated with 2.5 or
Fig. 3. 20(S)-Hydroxycholesterol (20S) induces Notch target gene expression through Hedgehog signaling. (A–C) M2 cells, which do express Smoothened
(Smo
þ/þ),were treatedat confluence withcontrol vehicle(control),5mM2 0 S, or 200ng/mLrecombinantmousesonichedgehog(Shh)withor withouta2
hour pretreatment with cyclopamine. After 48 hours of treatment, HES-1, HEY-1, and HEY-2 mRNAexpression was measuredby quantitativereal-time PCR.
(D–F) Smoothened ( / ) mouse embryonic fibroblasts (Smo
 /  MEFs) at confluence were treated with control vehicle (control), 5mM 20S, or 200ng/mL
Shh. After 24, 48, and72 hours of treatment, HES-1, HEY-1, and HEY-2 mRNAexpressionwas measured by quantitative real-timePCR. Fold changes in gene
expression relative to control cells were calculated using the DDCt method and reported as the mean of triplicate determination SD. (A–C)
   p<.0001
for control versus 20S or Shh and for 20S and Shh each in the presence versus absence of cyclopamine.
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(40,41) After 72 hours, colorimetric alkaline
phosphatase (ALP) activity assay on whole-cell extracts was
performed as described previously.
(30)
LXR-a, LXR-b, HES-1, and HEY-1 siRNA transfection
Both LXR-a and LXR-b siRNAs (ON-TARGETplus SMARTpool
Catalog No. L-040649-01-0010 and L-042839-00-0010) were
obtained from Dharmacon (Lafayette, CO, USA). To knock down
LXRs, M2 cells at 70% confluence in 6 well plates were
transfected with siRNA using DharmaFECT transfection reagent
(Dharmacon) to a final concentration of 25nM of each siRNA.
(42)
Knockdown of target genes was monitored at the mRNA level by
quantitative real-time PCR. At 100% confluence, transfected cells
were treated with control vehicle or 5mM2 0 S. After a 2 day
incubation, HES-1 and HEY-1 mRNA expression was measured by
quantitative real-time PCR. Both HES-1 and HEY-1 siRNAs were
obtainedfromQIAGEN(Valencia,CA,USA).ToknockdownHES-1
or HEY-1, M2 cells at 70% confluence in 6 well plates were
transfected with siRNA using DharmaFECT transfection reagent
(Dharmacon) to a final concentration of 50nM of each siRNA. At
100% confluence, transfected cells were treated with 5mM2 0 S.
After 3 days of incubation, alkaline phosphatase (ALP), bone
sialoprotein (BSP), and osteocalcin (OCN) mRNA expression was
measured by quantitative real-time PCR.
Statistical analysis
Statistical analyses were performed using the StatView 5
program. All p values were calculated using ANOVA and Fisher’s
projected least-significant-difference (PLSD) significance test. A
value of p<.05 was considered significant.
Results
20(S)-hydroxycholesterol induces the expression of
Notch target genes
In an initial microarray-based gene expression analysis
using Affymetrix mouse 430A gene chips,
(32) we found that
treatment of M2 cells with an osteogenic oxysterol combination
of 20Sþ22(S)-hydroxycholesterol (5mM each) for 48 hours
induced the expression of the Notch target genes HES-1 (Hairy/
Enhancer-of-Split 1, NM 008235, 2.55-fold induction, p¼.0017)
and HEY-2 (Hairy/Enhancer-of-Split related with YRPW motif 2,N M
013904, 2.6-fold induction, p¼.0009). In recent studies, we have
found that 20S is the most potent naturally occurring osteogenic
oxysterol in our M2 cell system and that the osteogenic effects of
5mM2 0 S used alone are quite significant, although less than
those of 20Sþ22S combination (data not shown). Hence further
studies were performed with 20S alone.
To confirm the microarray data, we then examined the effect
of 20S on Notch target gene expression in M2 cells using real-
time PCR. 20S significantly induced HES-1, HEY-1, and HEY-2
mRNA expression at 48 hours, whereas the nonosteogenic
oxysterols 7a-hydroxycholesterol and 7-ketocholesterol did not
induce these genes (Fig. 1A–C). Time-course studies showed
that 20S significantly induced HES-1 and HEY-1 mRNA expression
at 24, 48, and 96 hours in M2 cells, with maximum expression at
48 hours (see Fig. 1D, E), whereas significant induction of HEY-2
mRNA expression was observed only at 48 hours (see Fig. 1F).
Mechanism of HES-1 and HEY-1 induction by
20(S)-hydroxycholesterol
Since osteogenic oxysterols are novel activators of Hedgehog,
(32)
as well as liver X receptor (LXR) signaling,
(44) and Shh induces
Notch receptors and HES-1 expression,
(20–22) we examined
whether the induction of HES-1, HEY-1, and HEY-2 mRNA
expression in MSCs occurs through the Hedgehog or LXR
signaling pathway. 20S and Shh induced the expression of all
three Notch target genes in M2 cells, whereas the synthetic LXR
agonist TO-901317 (TO) did not induce the expression of these
genes, suggesting that the induction of Notch target genes
by 20S is mainly through Hedgehog signaling and not through
LXR signaling (Fig. 2A–C). TO activation of LXR under these
conditions was confirmed by a 10-fold increase in the mRNA
expression of the LXR target gene ABCA1 compared with control
cells (see Fig. 2D). Since nuclear hormone receptor conformation
may vary depending on the ligand used, and since the effect
of 20S on LXR conformation and activity may differ from what is
causedbyTO,
(43)wefurtherexaminedthepotentialroleofLXRin
mediating oxysterol-induced Notch target gene expression in
M2 cells using siRNA to knock down LXRa and LXRb expression
in these cells, as we have previously reported.
(42) Results showed
that 20S-induced HES-1 expression was not affected by LXR
siRNAs (see Fig. 2E), whereas HEY-1 expression was significantly
inhibited by LXR siRNA (see Fig. 2F), suggesting the role of LXR as
well as Hedgehog signaling in 20S-induced HEY-1 but not HES-1
expression. Tofurther confirm that20Sinduces HES-1, HEY-1, and
HEY-2 mRNA expression mainly through the Hedgehog signaling
pathway, M2 cells were treated with cyclopamine, a specific
inhibitor of the Hedgehog signaling pathway that binds directly
to and inhibits Smoothened.
(32) Results showed that cyclopa-
mine completely blocked 20S and Shh induction of HES-1, HEY-1,
and HEY-2 mRNA expression (Fig. 3A–C). We also examined
whether 20S and Shh could induce the expression of Notch
target genes in Smo
 /  mouse embryonic fibroblasts (Smo
 / 
MEFs), in which activation of Hedgehog signaling cannot
occur. 20S and Shh did not induce HES-1, HEY-1, and HEY-2
mRNA expression at all time points tested in Smo
 /  MEFs (see
Fig. 3D–F), suggesting that oxysterol induction of Notch target
genes requires the activation of the Hedgehog signaling
pathway.
20(S)-Hydroxycholesterol induces Notch target gene
expression independent of the canonical Notch
signaling pathway
In order to determine if 20S and Shh induce Notch target gene
expression in M2 cells through the canonical Notch signaling
pathway, we examined whether 20S and Shh induce the mRNA
expression of ligands and the Notch receptors Jagged-1 and -2;
Delta-1, -3, and -4; and Notch-1, -2, -3, and -4 that interact to
activate the canonical Notch signaling.
(1,2) Although mRNA for all
the Notch receptors (Notch-1, -2, -3, and -4) and ligands (Jagged-
OXYSTEROL INDUCES NOTCH TARGET GENE EXPRESSION Journal of Bone and Mineral Research 7871 and -2 and Delta-1, -3, and -4) are present in M2 cells (data not
shown), 20S and Shh caused only a significant induction of
Jagged-1 mRNA expression at 48 and 96 hours (Fig. 4A) but not
Notch-1 (Fig. 4F) or any of the other Notch signaling receptors or
ligands (data not shown). In addition, induction of Jagged-1
mRNA expression by 20S and Shh was completely blocked by
cyclopamine (see Fig. 4B), indicating that 20S and Shh both
induce Jagged-1 expression through Hedgehog signaling–
dependent mechanisms. However, Jagged-1 protein expression
was not increased by 20S or Shh compared with the control cells
at 48 and 72 hours (see Fig. 4G).
To further investigate the potential involvement of canonical
Notch signaling in the osteogenic response of MSCs to 20S and
Shh, we examined the effect of N-[N-(3,5-difluorophenacetyl-L-
alanyl)] S-phenylglycine t-butyl ester (DAPT), a canonical Notch
signaling inhibitor, on 20S and Shh induction of Notch target
788 Journal of Bone and Mineral Research KIM ET AL.gene expression to determine whether this process requires the
activation of Notch receptors and the production of Notch
intracellular domain (NICD). DAPT blocks canonical Notch
signaling by inhibiting g-secretase activity and the production
of NICD when Notch ligands bind to Notch receptor.
(45) DAPT
treatment significantly reduced both 20S and Shh induction of
HES-1 mRNA expression, as well as baseline HES-1 mRNA
expression compared with control cells (see Fig. 4C).
However,20SandShhstillsignificantlyinducedHES-1expression
in the presence of DAPT (DAPT alone versus 20SþDAPT or
ShhþDAPT). In contrast to its effects on HES-1 expression, DAPT
did not inhibit baseline or 20S- and Shh-induced levels of HEY-1
mRNA expression (see Fig. 4D), suggesting that 20S and Shh
induction of HEY-1 mRNA expression does not require the
canonical Notch signaling pathway. It must be noted that HEY-1
mRNA is expressed at a much lower level than HES-1 in control
M2 cells (data not shown) and hence the lack of DAPT effect on
its low baseline expression. In addition, we found that DAPT
significantly inhibited 20S-induced ALP mRNA expression on day
6 (see Fig. 4E), suggesting that baseline Notch signaling is
important for 20Sto fully induce osteogenic differentiation in M2
cells.
To further confirm the absence of canonical Notch signaling in
M2cellresponsesto20SandShh,weexaminedtheeffectsof20S
and Shh on CBF-1 luciferase reporter activity, nuclear localization
of NICD, and the expression of Notch target genes and
osteogenic genes (Fig. 5). If 20S or Shh induction of Notch
target gene expression is mediated at least in part through
canonical Notch signaling, it would be expected that CBF-1
luciferase activity would be induced by 20S and Shh and that
NICD protein accumulation would be increased in nuclear
extracts from 20S- and Shh-treated M2 cells. NICD over-
expression was used as a positive control for the activation of
CBF-1 luciferase reporter activity, and immobilized Jagged-1 was
used as a positive control to stimulate canonical Notch signaling
and nuclear NICD accumulation. We found that neither 20S nor
Shh induced CBF-1 luciferase reporter activity, whereas NICD
overexpression caused a robust increase in reporter activity
(see Fig. 5A). Moreover, 20S did not cause an increase in nuclear
levels of NICD protein, whereas cells cultured on immobilized
Jagged-1 exhibited increased NICD accumulation in the nucleus
(see Fig. 5G), and DAPT treatment inhibited baseline NICD
production and accumulation in the nucleus, as expected (data
not shown).
Finally, we examined the induction of the expression of
Notch target genes in parallel with osteogenic genes by 20S
and immobilized Jagged-1. Both 20S and immobilized Jagged-1
significantly increased HES-1 and HEY-1 mRNA expression
(see Fig. 5B, C). However, whereas 20S induced the mRNA
expression of the osteogenic genes alkaline phosphatase (ALP)
and bone sialoprotein (BSP), immobilized Jagged-1 did not
affect osteogenic gene expression (see Fig. 5D–F), indicating
that canonical Notch signaling per se does not stimulate
osteogenic differentiation of MSCs. In addition, we found that
culturing M2 cells on immobilized Jagged-1 had no effects on
mineralization at baseline or when induced by 20S (data not
shown).
HES-1 and HEY-1 knockdown significantly inhibits
20(S)-hydroxycholesterol-induced osteogenesis
in MSCs
We used siRNA gene knockdown studies to determine whether
increased HES-1and/or HEY-1 expression is required for 20S
induction of osteogenic differentiation in M2 cells. Treatment
with HES-1 or HEY-1 siRNA was found to reduce 20S induction of
HES-1 and HEY-1 mRNA expression, respectively, by over 70% at
3 days compared with control scrambled siRNA-transfected cells
(Fig.6A,E).WesternblotanalysisofHES-1proteinexpressionalso
showed that HES-1 siRNA reduced baseline as well as 20S-
induced HES-1 protein levels (see Fig. 6I). Moreover, HES-1 and
HEY-1siRNAdidnotinhibit20S-inducedABCA1mRNAexpression
(see Fig. 6J), indicating that siRNA knockdown was specific to
HES-1 and HEY-1 and not due to any toxic effects. HES-1 siRNA
treatment inhibited 20S-induced mRNA expression of the
osteogenic genes ALP, BSP, and OCN by 70%, 90%, and 73%,
respectively(seeFig.6B–D),althoughbaselineexpressionofOCN
also was inhibited to the same degree. In addition, treatment
with HEY-1 siRNA also caused a significant inhibition of ALP, BSP,
and OCN mRNA expression, although to a lesser extent than that
achieved by HES-1 siRNA (see Fig. 6F–H), suggesting that both
HES-1 and HEY-1 play a significant role in 20S induction of
osteogenesis in MSCs.
Fig. 4. Effects of 20(S)-hydroxycholesterol (20S), sonic hedgehog (Shh), and DAPT on Jagged-1 and Notch target gene expression. (A) M2 cells at
confluence were treated with control vehicle (control), 5mM 20S, or 200ng/mL Shh. After 24, 48, and 96 hours of treatment, Jagged-1 mRNA expression
was measured by quantitative real-time PCR. (B) M2 cells at confluence were treated with control vehicle (control), 5mM2 0 S, or 200ng/mL Shh with or
without a 2 hour pretreatment with cyclopamine. After 48 hours of treatment, Jagged-1 mRNAexpression was measuredby quantitative real-time PCR. (C,
D) M2 cells at confluence were treated with control vehicle (control), 5mM2 0 S, or 200ng/mL (Shh) with or without a 2 hour pretreatment with 10mM
DAPT. After 48 hours of treatment, HES-1 and HEY-1 mRNA expression was measured by quantitative real-time PCR. Fold changes in gene expression
relativeto controlcells were calculated usingthe DDCt method andreported as the mean of triplicatedetermination SD. (E) M2 cells at confluence were
treatedwith controlvehicle(control)or 5mM2 0 S withor withouta2 hourpretreatmentwith10mM DAPT.After 6 days oftreatment,alkalinephosphatase
(ALP) mRNA expression was measured by quantitative real-time PCR. ( F) M2 cells were treated with control vehicle (control), 5mM2 0 S, or 200ng/mL Shh.
ImmobilizedJagged-1wasusedas apositivecontrol.After48hoursoftreatments, Notch-1mRNAexpressionwasmeasuredbyquantitativereal-timePCR.
(G) M2 cells at confluence were treated with control vehicle (control), 5mM2 0 S, or 200ng/ml Shh for 48 or 72 hours. Whole-cell lysates were collected for
WesternblottingusingantibodiestoJagged-1andb-actin.(A)
   p<.0001forcontrolversus20SorShhat48hoursandforcontrolversusShhat96hours.
 p<0.05controlversion20Sat96hours.(B)
   p<.0001forcontrolversus20SorShhandfor20SandShhinthepresenceversusabsenceofcyclopamine.
(C)
   p<.0001 for control versus 20S or Shh in the absence of DAPT and for 20S and Shh in the presence versus absence of DAPT;
  p<.001 for control
versus 20S versus Shh all in the presence of DAPT. (D)
   p<.0001 for control versus 20S and Shh in the presence or absence of DAPT. (E)
   p<.0001 for
control and 20SþDAPT versus 20S and
 p<.05 for control versus DAPT. ( F)
   p<.0001 for control versus immobilized Jagged-1.
OXYSTEROL INDUCES NOTCH TARGET GENE EXPRESSION Journal of Bone and Mineral Research 789Fig. 5. 20(S)-Hydroxycholesterol (20S) and Shh induce Notch target genes independent of the canonical Notch signaling pathway. (A) M2 cells at 70%
confluence in a 24 well plate were transiently transfected with CBF-1 luciferase reporter construct pTK-luciferase plasmid and pTK-Renilla-luciferase
plasmid (Promega, Madison, WI, USA) using Fugene 6 Transfection Reagents from Roche (Indianapolis, IN, USA). Twenty-four hours after transfection, the
cells were treated with control vehicle, Notch interacellular domain (NICD) overexpression vector, 5mM2 0 S, or 200ng/mL Shh for 24 and 48 hours. Notch
activation of CBF-1 was normalized to Renilla luciferase activity. Transfection efficiency was monitored by cotransfecting with a plasmid expressing green
fluorescentprotein.(B,C,E, F)M2cellsweretreatedatconfluencewithcontrolvehicleor5mM20Sorculturedon2.5or5mg/mLimmobilizedJagged-1for
real-time PCR and alkaline phosphatase (ALP) activity analyses. After 48 hours of treatment, HES-1, HEY-1, ALP, and bone sialoprotein (BSP) mRNA
expression was measured by quantitative real-time PCR. (D) After 72 hours of treatment, ALP activity using whole-cell extracts was measured by a
colorimetric method. Fold changes in gene expression comparedwith the control cells were calculated using the DDCt method and reported as the mean
of triplicate determination SD. (G) M2 cells at confluence were treated with control vehicle (control), cultured on 5mg/mL immobilized Jagged-1, or
treated with 5mM2 0 S. After 48 and 72 hours of treatment, nuclear extracts were collected for Western blotting using antibodies to NICD and b-actin. (A)
   p<.0001 for control versus NICD. (B)
   p<.0001 for control versus 20S and Jagged-1 (2.5 and 5mg/mL). (C)
  p<.001 for control versus 20S;
   p<.0001 for control versus Jagged-1 (2.5 and 5mg/mL). (D–F)
   p<0.0001 for control versus 20S.
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Inthisstudywedemonstratedthat20Sinducestheexpressionof
the Notch target genes HES-1, HEY-1, and HEY-2 in murine M2
MSCs. Induction of Notch target gene expression by 20S appears
to be mediated through Hedgehog signaling because cyclopa-
mine, a Hedgehog pathway inhibitor, completely blocked 20S
induction of Notch target gene expression, and 20S did not
induce Notch target genes in Smo
 /  MEFs, which cannot
generate Hedgehog pathway signaling. However, unlike HES-1,
LXR activation by 20S appears to cooperate with Hedgehog
signaling to induce HEY-1 expression in response to 20S and
therefore is inhibited significantly by LXR siRNA. A similar pattern
of responses was observed when MSCs were treated with Shh. A
recent study in C3H10T1/2 embryonic fibroblasts and MNS70
neuronal cells by Ingram and colleagues
(22) suggested that Shh
regulates HES-1 expression through a mechanism that is
independent of canonical Notch signaling.
(22) It was shown that
DAPT decreased baseline HES-1 levels in both cell types but that
there was no reduction in the fold change in HES-1 mRNA
expression induced by Shh treatment in the presence of DAPT,
suggesting that DAPT inhibited baseline and not Shh-induced
HES-1 expression.
(22) Moreover, it was reported recently that Shh
directly regulates HES-1 expression in retinal progenitor cells
through a Gli2-dependant and Notch-independent mechan-
ism.
(24) Based on similar findings in our present studies, we also
conclude that in MSCs, the canonical Notch signaling inhibitor
DAPT inhibits baseline but not 20S- or Shh-induced HES-1
expression. Moreover, we also found that DAPT treatment
significantly inhibited baseline as well as 20S-induced ALP mRNA
expression on day 6, which most likely is due to the inhibition of
baseline HES-1 expression with minimal, if any, effects on 20S-
induced HES-1 expression.
In addition, DAPT did not inhibit 20S- or Shh-induced HEY-1
expression, whereas cyclopamine completely inhibited its
expression. The lower baseline level of expression of HEY-1
comparedwithHES-1andtheinabilityofDAPTtoinhibitbaseline
HEY-1 expression while inhibiting baseline HES-1 expression
suggest differences in transcriptional regulation of these Notch
target genes in MSCs. Our data also showed that 20S and Shh
induction of Notch target genes was not accompanied by an
increase in CBF-1 luciferase reporter activity or NICD protein
accumulation in the nucleus, indicating that the induction of
Notch target gene expression by 20S or Shh occurs independent
of NICD-CBF-1 activation. Although we found that 20S did
moderately induce Jagged-1 mRNA expression, Jagged-1 protein
levels were not induced by 20S or Shh beyond baseline levels.
This finding confirms the lack of any increase in either CBF-1
reporter activity or nuclear content of NICD, which would have
been caused if Jagged-1 protein expression was induced by 20S
or Shh. In a preliminary screen of 5kb upstream of the
transcription start site in mouse HES-1 and HEY-1 genes, we
found several potential Gli-binding sites (data not shown),
suggestingthat Glimay directly regulate the expressionofNotch
target genes. Indeed, a recent report demonstrated direct
binding of Gli2 to HES-1 promoter in retinal progenitor cells
treated with Shh.
(24) Altogether, our findings demonstrate and
confirm the activation of Notch target genes through a
Hedgehog signaling–dependent mechanism in MSCs.
Previously we reported that specific oxysterols stimulate
osteogenic differentiation of MSCs through various signaling
pathways, including Hedgehog, Wnt, PKC, PKA, and PI3K.
(32,33,40)
The present study suggests that induction of HES-1 and HEY-1
expression by the osteogenic oxysterol 20S mediates stimulation
of osteogenic differentiation of MSCs because HES-1 and HEY-1
knockdown significantly reduced oxysterol induction of the
expression of the osteogenic genes ALP, BSP, and OCN.A
potential role for HES-1 in the regulation of the osteogenic
differentiation of pluripotent MSCs has been reported pre-
viously.
(5,15,46) McLarren and colleagues
(15) demonstrated that
HES-1 physically interacts with RUNX2, a master regulator of
osteogenesis, and potentiates RUNX2-mediated transcriptional
activity by interfering with interaction of RUNX2 with corepres-
sors (TLE proteins).
(15) Moreover, stimulation of HES-1 expression
bycanonical Notch signaling hasbeen shown toincrease BMP-2-
induced ALP activity and type I collagen and RUNX2 mRNA
expression, whereas inhibition of Notch signaling by the
dominant-negative extracellular domain of Notch-1 or HES-1
siRNA significantly reduced BMP-2-induced responses.
(5) These
reports are consistent with a positive regulatory role for HES-1 in
oxysterol-inducedosteogenesis.Althoughitisplausiblethat20S-
inducedHES-1expressionenhancesosteogenicdifferentiationof
MSCs through positive regulation of Runx2, future studies will
examine this possibility directly.
HEY-1 also may play a regulatory role in osteogenic
differentiation. Our present studies suggest that the induction
of HEY-1 by 20S oxysterol plays an important role in 20S-induced
osteogenic differentiation of MSCs. This finding is in agreement
with the results of a recent study of BMP-9 induction of
osteogenic differentiation in pluripotent C3H10T1/2 embryonic
fibroblasts.
(17) Sharff and colleagues demonstrated that BMP-9
significantly induced HEY-1 at an early stage of BMP-9 induction
of osteogenic differentiation. HEY-1 knockdown caused the
inhibition of BMP-9-induced osteogenic differentiation both in
vitro and in vivo, whereas HEY-1 overexpression increased BMP-
9-mediated stimulation of late-stage mineralization of bone
matrix.
(17) It also was demonstrated that HEY-1 and RUNX2
synergistically increased BMP-9-induced osteogenic differentia-
tion.
(17) However, other studies have suggested that HEY-1 may
act as a negative regulator of osteogenic differentiation.
(18,47) For
example, it has been shown that BMP-2 stimulates HEY-1
expressioninmouseMC3T3andC2C12cellsandthatHEY-1gene
knockdown with siRNA significantly increases bone matrix
mineralization, suggesting that HEY-1 is a negative regulator of
osteoblast maturation.
(47)
In vivo studies of the role of Notch signaling in bone formation
also have resulted in complex findings. Recently, Hilton and
colleagues
(18) showed that mice lacking the key Notch signaling
components Presenilin-1 and -2 and Notch-1 and -2 have
excessive cancellous bone development and a decreased
number of bone marrow mesenchymal progenitors compared
with WT mice, suggesting that Notch signaling may play a
positive role inmaintaining the mesenchymalcell progenitor cell
population while inhibiting its osteogenic maturation.
(18)
However, the decreased progenitor pool observed in Notch-
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suggesting that Notch signaling is important in the long-term
maintenance ofa pool of mesenchymalcell progenitors required
for bone homeostasis.
(18) Thus, although short-term inhibition of
Notch signaling might augment bone formation by enhancing
osteoblast maturation, in the longer term, Notch signaling
appears to be essential for coordinating maintenance of the
mesenchymal cell progenitor pool and the proper regulation of
osteoblastogenesis and bone formation. Moreover, it has been
reported that mice deficient in Dll-3 or Presenilin-1, key
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severely impaired skeletal development, suggesting that Notch
signaling is important in this process.
(8,13,14) Accordingly,
although the Notch signaling pathway appears to play an
important role in osteogenic differentiation and bone formation,
the specific mechanisms of its actions in this regard remain
undefined. Furthermore, since we found that activation of
canonical Notch signaling did not induce osteogenic differentia-
tion of MSCs in this study, it will be important to further identify
the interactions between canonical Notch signaling and other
signal-transduction pathways that result in enhanced osteogen-
esis and bone formation. Our present findings suggest that
canonical Notch signaling may act in cooperation with Hedge-
hog signaling to positively regulate osteogenesis.
In summary, our studies demonstrated that the osteogenic
oxysterol 20S and Shh both induce the expression of the Notch
target genes HES-1, HEY-1, and HEY-2 in MSCs both through
activation of Hedgehog signaling and via a pathway indepen-
dent of canonical Notch signaling (Fig. 7). Interestingly, as
suggested by our studies using siRNA knockdown of LXRs, we
found that LXR activation by 20S plays a role in the induction of
HEY-1 but not HES-1 mRNA expression. Such effects of LXR
activation on HEY-1 expression is perhaps through cooperation
with20S-inducedHedgehogsignalingbecauseinductionofHEY-
1 expression in cells cultured on immobilized Jagged-1, which
does not stimulate Hedgehog pathway activity, did not induce
osteogenesis. In addition, our studies showed that HES-1 and
HEY-1 play a significant role in oxysterol-induced osteogenic
differentiation of MSCs. Given the differences in the reports of
the role of Notch target genes in osteogenesis, various
experimental systems, and their apparent role in mediating
theosteogenic effects ofoxysterols invitro,future mechanistic in
vivo studies are required to determine the role of HES and HEY
genes in oxysterol-induced osteogenesis and bone formation.
Furthermore, given the subtle but important differences in
osteogenic programs used by osteoblasts derived from the
neural crest (e.g., calvarial osteoblasts) versus bone marrow
mesenchymal cells, it will be important that future studies that
elucidatetheinvivomolecularmechanismsofoxysterol-induced
osteogenesis also determine any differences that might exist in
oxysterol actions when targeting osteoprogenitors from differ-
ent origins. Development of an improved understanding of the
molecularmechanismsbywhichosteogenicoxysterols stimulate
the osteogenic differentiation of MSCs should enhance current
understanding of the regulation of osteogenesis and potentially
could lead to the development of novel oxysterol-based
therapies for interventions in osteoporosis and enhancement
of bone healing.
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Fig. 7. Regulation of osteogenic differentiation of bone marrow stromal
cells (MSCs) by 20(S)-hydroxycholesterol (20S). Osteogenic oxysterol 20S
induces Notch target gene expression in MSCs mainly through activation
of hedgehog (Hh) signaling and in part through LXR signaling. 20S-
induced osteogenesis is regulated in part by Notch target genes HES-1
and HEY-1.
Fig. 6. HES-1andHEY-1siRNAsignificantlyinhibit20(S)-hydroxycholesterol(20S)–inducedosteogenicgeneexpressioninMSCs.ToknockdownHES-1and
HEY-1 expression, M2 cells at 70% confluence were transfected with siRNA to a final concentration of 50nM of either siRNA. At 100% confluence,
transfected cells were treated with control vehicle or 5mM2 0 S for 3 days. After 3 days of incubation, HES-1, HEY-1 (A, E), alkaline phosphatase (ALP)( B, F),
bone sialoprotein (BSP)( C, G), and ABCA1 mRNA expression (I) was measured by quantitative real-time PCR. Fold changes in gene expression relative to
control cells were calculated using the DDCt method and reported as the mean of triplicate determination SD. Osteocalcin (OCN) mRNA expression was
measured after 6 days of incubation (D, H). For Western blotting of HES-1 and b-actin, whole-cell lysates were collected after 72 hours of control vehicle or
5mM2 0 S treatment in M2 cells transfected with either scramble control or HES-1 siRNA (J). (A)
  p<.001 for control versus20S and for 20S in the presence
of scrambled versus HES-1 siRNA;
 p<.05 for control in the presence of scrambled versus HES-1 siRNA. (B, C)
   p<.0001 for control versus 20S in the
presence of scrambled or HES-1 siRNA and for 20S in the presence of scrambled versus HES-1 siRNA. (D)
   p<.0001 for control in the presence of
scrambled versusHES-1 siRNA andfor 20S in the presenceof scrambled versusHES-1 siRNA andfor control versus 20S in thepresenceof scrambled siRNA.
(E)
   p<.0001 for control in the presence of scrambled versus HEY-1 siRNA and for 20S in the presence of scrambled versus HEY-1 siRNA and for control
versus20S in the presence ofscrambled siRNA.( F, G)
   p<.0001 for control versus20S in the presenceandabsenceof HEY-1 siRNA;
   p<.001 for 20S in
the presence of scrambled versus HEY-1 siRNA. (H)
   p<.0001 for control versus 20S in the presence of scrambled siRNA and for 20S in the presence of
scrambled versus HEY-1 siRNA. (J)
 p<.05 for control versus 20S in the presence of scrambled or either HES-1 or HEY1 siRNA.
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